Blog / Archives
Biotech Bear Market: But It Is Time to Start Trading…11/9 Updates on Rally
Update at Close 11/9/18 Remain Cautious as Rally Fails The NASDAQ down 1.6% and Russell 2000 down 1.8%, sold off killing hopes of a continued Post-Election rally. The biotech sector is for...
Biotech Bull Market Under Pressure: Now Flat to Down in 2018…Rally 10/16!…Updates 10/29 Bear Market
Update 10/29 It's a bear market in biotech so wait for the bottom. Have plenty of cash on hand. IBB at $102.77 down over 5% YTD. Clues: IJR and XBI need to bottom. ======= Update 10/27 Still on...
Biotech Momentum Lost Mired in Macro-Economic News Cycle: China, FED,Trade etc.
Biotech Momentum Lost Technical Breakdown: XBI Near April Bottom but XLV Looks Good Market Looking for Growth from Large Cap Earnings 10 year auction has tepid demand at Yield of 3.225%, NASDAQ at...
Rayno BioBeat #6: Biotech Sell-Off with Broad Market Concerns…Updates
Update 10/5/18 Very Weak Technicals after Biotech Sell-Off NASDAQ market closed off the lows down 1.16% at 7788. Biotech ETF IBB down 1.15% just above 3 month support of 116. Biotech ETF XBI down...
Mid-Cap Biopharma 2018 Stock Performance as of 9/30…Updates
Update-10/1 Rally Fades Early Today...NASDAQ Moves to Red An early rally faded quickly today after an initial spike from new "NAFTA" deal. Biotech ETFs were red IBB down 0.63% and XBI down 1.34%....
Biotech Bounces to Trend Line-Clinical News Lifts Stocks…Update ALXN, TSRO
Update 9/26: FED Rate Hike Curbs Traders but Biotech Rolls On The market dipped slightly then went red about 3:30P EDT resulting in a 0.4% loss for the Dow. Main rates will rise to the 2 to 2.25%...
Biotechs Bounce Back, Dow and S&P Hit New Highs
Biotechs Bounce Back: Up From September Lows-Markets Surge Ahead XBI Up 1.66% to $97.16 up from 3 month tech support of $95;IBB up 1.39%. Broad rally brings Dow up 1%, S&P up 0.81% to fresh...
Biotech Weakens Further: September Down 5% -Updates ABBV GWPH TSRO
Update 9/19 : Lightened up on Abbvie (ABBV) in low 90s with news of CA lawsuit on Humira kickbacks. Amgen (AMGN) hits 52 week high in $204 range, strong hold up 14.9% YTD. GW Pharmaceuticals (GWPH)...
Rayno Biopharma Portfolio Movers: AMGN TSRO…Updates
9/16 The Week That Was: September Trending Down for Biotech NASDAQ-100 Holding (QQQ) at 184 up 1.7% last week. Large caps all weak on Friday; key will be Q3 earnings. FBT, IBB and XBI flat for the...
Biotech Weakness but why Large Caps?…Updates
Update: 10:10a Tesaro (TSRO) Soars 15% to $38, short covering or bargain hunters? News item: expansion of Zejula Combo Trial in NSCLC ========= Biotech Weakness in Large Caps Mid-Caps Have Continued...